Bethesda, Md. – Donna M. Regan, MT(ASCP)SBB, director of the St. Louis Cord Blood Bank and Cellular Therapy Laboratory at SSM Health Cardinal Glennon Children’s Hospital, was installed as president of AABB (formerly the American Association of Blood Banks) for the 2015-2016 term at the Association’s 2015 Annual Meeting in Anaheim. Regan succeeds Lynne Uhl, MD, as president.
Regan has been an active member of AABB since 1998, serving as chair of the Clinical, Scientific and Regulatory Council, the Governance Committee, and the Human Resources Committee. In addition, she has served two terms as an appointee to the United States Department of Health and Human Services’ Advisory Council on Blood Stem Cell Transplantation. Regan currently serves on the Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee as well. In these and other advisory and collaborative roles, she has worked to influence regulation, legislation and public policy related to cellular therapies.
In the course of her career, Regan assisted the development of a pediatric stem cell transplant program and a mission-driven public cord blood bank. She has participated in a number of clinical research studies, and led the St. Louis Cord Blood Bank’s successful pursuit of FDA licensure for their allogeneic cord blood product. Regan has also authored a number of manuscripts and book chapters and served as a faculty moderator and director for many professional meetings.
Regan received her bachelor’s degree in medical technology from St. Louis University and later earned her Specialist in Blood Banking.
AABB members also elected Zbigniew M. Szczepiorkowski, MD, PhD, FCAP, as the 2016-17 Association president; Mary Beth Bassett, BS, MT(ASCP) as vice president; and Michael F. Murphy, MD, FRCP, FRCPath, as secretary of the AABB Board of Directors.
To view the complete list of the AABB Board of Directors, please visit: http://www.aabb.org/membership/governance/Pages/default.aspx
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership consists of nearly 2,000 institutions and 8,000 individuals, including physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. Members are located in more than 80 countries. For more information, visit www.aabb.org.